South Shore Capital Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,086
Closed -$254K 87
2022
Q2
$254K Hold
5,086
0.53% 62
2022
Q1
$261K Hold
5,086
0.43% 77
2021
Q4
$255K Buy
5,086
+603
+13% +$29.8K 0.42% 80
2021
Q3
$216K Buy
4,483
+153
+4% +$7.78K 0.39% 87
2021
Q2
$228K Hold
4,330
0.4% 88
2021
Q1
$214K Hold
4,330
0.21% 118
2020
Q4
$210K Buy
+4,330
New +$214K 0.21% 116

Other funds holding SNY

South Shore Capital Advisors's SNY Position: Q3 2022 in Review

South Shore Capital Advisors sold out of Sanofi (SNY) in Q3 2022, closing a stake of 5,086 shares — an estimated $254K sold.

South Shore Capital Advisors first reported a position in SNY in Q4 2020 and held it in 7 quarters. The position peaked at $261K in Q1 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • South Shore Capital Advisors reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • South Shore Capital Advisors sold 5,086 Sanofi shares in Q3 2022, an estimated $254K.
  • South Shore Capital Advisors first reported a position in Sanofi in Q4 2020 and held it in 7 quarters.
  • South Shore Capital Advisors's Sanofi position peaked at $261K in Q1 2022.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on South Shore Capital Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.